FDA Inspection 1190591 — American Red Cross Blood Services Alabama and Central Gulf Coast Region
The FDA completed an inspection of American Red Cross Blood Services Alabama and Central Gulf Coast Region on November 1, 2022 in Huntsville, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- November 1, 2022
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Huntsville, AL (United States)